The pH-dependent reduction of Adriamycin catalysed by NADH:cytochrome b5 reductase
- 1 September 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 84 (2) , 149-154
- https://doi.org/10.1016/0304-3835(94)90369-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The consequences of doxorubicin quinone reduction in vivo in tumour tissueBiochemical Pharmacology, 1992
- Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicityPharmacology & Therapeutics, 1990
- Overview of enzyme systems involved in bioreduction of drugs and in redox cyclingBiochemical Pharmacology, 1986
- Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sarcoplasmic reticulumBiochemical and Biophysical Research Communications, 1985
- [13] Catalase in vitroPublished by Elsevier ,1984
- Generation of hydroxyl radical by anticancer quinone drugs, carbazilquinone, mitomycin C, aclacinomycin A and adriamycin, in the presence of NADPH-cytochrome P-450 reductaseBiochemical Pharmacology, 1982
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Effects of adriamycin on surface properties of sarcoma 180 ascites cellsBiochemical Pharmacology, 1976
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- One-electron-transfer reactions in biochemical systems III. One-electron reduction of quinones by microsomal flavin enzymesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1969